Medtronic plc (MDT) operating KPIs
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic coronary & Peripheral Vascular (CPV — Legacy through FY2026Q4) — Worldwide Revenue ($M) ($M)
Effective Q1 FY2027, Medtronic reorganized Cardiovascular from 3 divisions (CRHF, SHA, CPV) into 4 divisions (EP Therapies, IC Therapies, CV Surgery, PV Health) without publishing Q2–Q4 FY2026 restated quarters yet; legacy 3 divisions are retained through FY2026Q4 per Step 5, while new divisions (<3 consecutive quarters) are in excluded.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Coronary & Peripheral Vascular (CPV — Legacy through FY2026Q4) — Worldwide Revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Apr 30, 2026 | 2,656 | +4.8% | Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗ |
| FY2025 | Apr 30, 2025 | 2,535 | +2.3% | Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗ |
| FY2024 | Apr 30, 2024 | 2,478 | +4.3% | Medtronic SEC 8K_EARNINGS — FY2025Q4 (filed 2025-05-21) ↗ |
| FY2023 | Apr 30, 2023 | 2,375 | -3.5% | Medtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗ |
| FY2022 | Apr 30, 2022 | 2,460 | +4.5% | Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗ |
| FY2021 | Apr 30, 2021 | 2,354 | -5.3% | Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗ |
| FY2020 | Apr 30, 2020 | 2,486 | -10.4% | Medtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗ |
| FY2019 | Apr 30, 2019 | 2,774 | – | Medtronic Form 10-K — FY2021 (filed 2021-06-25) ↗ |
Breakdown
What makes up coronary & peripheral vascular (cpv — legacy through fy2026q4) — worldwide revenue ($m)
- Coronary & Peripheral Vascular (CPV — Legacy through FY2026Q4) — Organic Revenue Growth YoY (%)2.5% · FY2026
- Coronary & Peripheral Vascular (CPV — Legacy through FY2026Q4) — Foreign Currency Impact ($M)57 · FY2026
- Coronary & Peripheral Vascular (CPV — Legacy through FY2026Q4) — Reported Revenue Growth YoY (%)4.8% · FY2026
- Coronary & Peripheral Vascular (CPV — Legacy through FY2026Q4) — U.S. Revenue ($M)1,107 · FY2026
- Coronary & Peripheral Vascular (CPV — Legacy through FY2026Q4) — International Revenue ($M)1,549 · FY2026
Cite this data
StockData. (2026). Medtronic Coronary & Peripheral Vascular (CPV — Legacy through FY2026Q4) — Worldwide Revenue ($M) ($M), annual FY2019–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/cv-cpv-leg-ww-rev
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.